Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/09/1997 | CN1147259A Method of separating protective components of bordetella pertussis |
04/09/1997 | CN1146995A Thrombopoietin and its producing process |
04/08/1997 | USRE35492 Wound treatment employing biologically active ion channel forming peptides and proteins |
04/08/1997 | USRE35491 Methods and compositions for detecting human tumors |
04/08/1997 | US5618927 Incubation in solution of tris |
04/08/1997 | US5618926 Immunoassay reagents |
04/08/1997 | US5618924 BMP-2 products |
04/08/1997 | US5618921 Antibodies for detection of human MDM2 protein |
04/08/1997 | US5618920 Immunoglobulins |
04/08/1997 | US5618919 Centrifuging whole blood in bowl-type centrifuge, separating erythrocytes from leukocytes, during centrifuging erythrocytes get disrupted forming endotoxin-free hemoglobin which is semi-synthetic blood-substitute |
04/08/1997 | US5618918 Human brain sodium dependent inorganic phosphate cotransporter |
04/08/1997 | US5618917 Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells |
04/08/1997 | US5618916 Purified protein which functions as a mycobacterial receptor for fibronectin |
04/08/1997 | US5618915 Increased inhibitory effect against serine protease; reduced nephrotoxicity, reduced positive net charge and reduced stability |
04/08/1997 | US5618914 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
04/08/1997 | US5618913 Insulin analogues |
04/08/1997 | US5618789 Functional human factor VIII |
04/08/1997 | US5618788 Preparation of functional human factor VIII and pharmaceutical treatment therewith |
04/08/1997 | US5618785 Antiischemic agents, antitumor agents, antiarthritic agents |
04/08/1997 | US5618720 Cells expressing calcium channel α2 subunit-encoding DNA, optionally with a reporter gene for screening assays |
04/08/1997 | US5618717 DNA encoding human AlkB |
04/08/1997 | US5618715 Pure nucleotide sequence encoding oncostatin m |
04/08/1997 | US5618714 Methods for producing protein C |
04/08/1997 | US5618713 Mutants of human antithrombin III |
04/08/1997 | US5618712 Purified, isolated recombinant dna molecule coding for human lysozyme |
04/08/1997 | US5618700 IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same |
04/08/1997 | US5618699 Plant virus vector comprising foreign gene linked downstream of coat protein gene of tobacco mosaic virus via nucleotide sequence which causes readthrough, so that fusion protein is produced in plant |
04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
04/08/1997 | US5618697 Process for preparing a desired protein |
04/08/1997 | US5618696 Culture product polypeptide enzyme inhibitor |
04/08/1997 | US5618695 DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells |
04/08/1997 | US5618694 Tumor diagnosis |
04/08/1997 | US5618693 Interleukin-2 signal transducers and binding assays |
04/08/1997 | US5618691 Recombinant DNA encoding a eukaryotic tyrosine kinase target protein |
04/08/1997 | US5618690 Method of using an ER-located endoprotease |
04/08/1997 | US5618678 Methods for detecting PDGF agonist or antagonist activity using PDGF .alpha. |
04/08/1997 | US5618677 Human brain sodium dependent inorganic phosphate cotransporter assay |
04/08/1997 | US5618676 Expression of polypeptides in yeast |
04/08/1997 | US5618675 Exposing sample to a specific polypeptide which binds lipopolysaccharide, detecting binding; useful for diagnosis of gramnegative sepsis, endotoxin shock or disseminated intravascular coagulation |
04/08/1997 | US5618670 Detection method for c-raf-1 genes |
04/08/1997 | US5618666 Nucleic acids derived from Salmonella typhi and detection of Salmonella using thereof |
04/08/1997 | US5618542 Vaccines comprising antigenic polypeptides of Taenia ovis |
04/08/1997 | US5618541 Vaccine against Neisseria meningitidis infections |
04/08/1997 | US5618540 Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified state |
04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
04/08/1997 | US5618533 Flagellin-based polypeptides for the diagnosis of lyme disease |
04/08/1997 | US5618532 Dirofilaria immitis Gp29 proteins and uses thereof |
04/03/1997 | WO1997012246A1 Tumour-specific p450 protein |
04/03/1997 | WO1997012243A1 Method for assaying antigen relating to mental stress disorders |
04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
04/03/1997 | WO1997012054A1 Neutrophil chemotactic lymphokine, and drug and kit for the diagnosis of drug hypersensitive granulocytopenia containing the same |
04/03/1997 | WO1997012049A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
04/03/1997 | WO1997012048A1 Recombinant viruses incorporating a protease cleavable protein |
04/03/1997 | WO1997012044A2 Pichia secretory leader for protein expression |
04/03/1997 | WO1997012043A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
04/03/1997 | WO1997012040A1 GENE THERAPY WITH MODIFIED p65 PROTEINS |
04/03/1997 | WO1997012038A1 Novel peptides useful in enhancement of fsh action |
04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
04/03/1997 | WO1997012036A2 Bone stimulating factor |
04/03/1997 | WO1997012035A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
04/03/1997 | WO1997012032A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
04/03/1997 | WO1997011971A1 Porcine cell interaction proteins |
04/03/1997 | WO1997011970A1 Cytostatin ii |
04/03/1997 | WO1997011969A1 Type cc chemokine-like protein |
04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
04/03/1997 | WO1997011967A1 Viscum album white mistletoe extract |
04/03/1997 | WO1997011966A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
04/03/1997 | WO1997011962A1 Cyclic peptide analogs of somatostatin |
04/03/1997 | WO1997011961A1 Peptide derivatives having endothelin receptor antagonistic activity |
04/03/1997 | WO1997011957A1 Conjugates of a polypeptide and a biocompatible polymer |
04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
04/03/1997 | WO1997011714A1 Chemokine inhibitor |
04/03/1997 | WO1997011713A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
04/03/1997 | WO1997011669A2 Mhc-class ii restricted melanoma antigens and their use in therapeutic methods |
04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
04/03/1997 | WO1997003198A3 Nucleotide and amino acid sequence and uses thereof |
04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
04/03/1997 | WO1997001634A3 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
04/03/1997 | WO1996039516A3 Targets for breast cancer diagnosis and treatment |
04/03/1997 | WO1996038473A3 Antimicrobial cationic peptides |
04/03/1997 | DE19531226C1 Pharmaceutical compsn. for prevention or treatment of viral disease |
04/03/1997 | CA2233367A1 Short forms of chemokine .beta.-8 |
04/03/1997 | CA2233361A1 Cytostatin ii |
04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
04/03/1997 | CA2233040A1 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
04/03/1997 | CA2233031A1 Gene therapy with modified p65 proteins |
04/03/1997 | CA2232950A1 Novel peptides useful in enhancement of fsh action |
04/03/1997 | CA2232706A1 Chemokine inhibitor |